LifeVantage (LFVN) investor relations material

Company overview and leadership transition

• Headquartered in Salt Lake City, with over 20 years in business and 14 years publicly traded on Nasdaq.

• Recently underwent a CEO transition: Steve Fife retired, Michael Beindorff is interim CEO, and Terrence Moorehead will start as CEO on August 5.

• Leadership changes were planned over 18 months, aiming to position for future growth.

• Terrence Moorehead brings significant direct selling and international experience from Nature’s Sunshine and Avon.

Strategic focus and growth opportunities

• Business is primarily North America-focused, with 80% of revenue from the region and operations in 18 markets.

• Significant international expansion opportunities identified, especially in Europe and Southeast Asia.

• International growth expected to accelerate over the next 12–18 months, with product registration as the main barrier.

• Expansion is not capital intensive, mainly requiring product registration and supply chain setup.

Product innovation and market dynamics

• Launched MindBody, a natural GLP-1 weight management product, in October 2024, achieving record sales initially.

• Faced headwinds from increased competition and price pressure in the GLP-1 market, leading to a strategic refocus on core products.

• MindBody expected to contribute 8–10% of revenue but not as a primary growth driver.

• Refocused sales efforts on core products like Protandim and collagen, leveraging a stack strategy.